Bladder cancer is a complex disease associated with high morbidity and mortality rates if not
treated optimally. Awareness of haematuria as the major presenting symptom is paramount …

Bladder cancer has a high incidence and involves high associated morbidity and mortality.
Since its initial clinical suspicion, early diagnostic confirmation and multimodal treatment …

Purpose: Patients presenting with microhematuria represent a heterogeneous population
with a broad spectrum of risk for genitourinary malignancy. Recognizing that patient-specific …

Due to the lack of disease-specific symptoms, diagnosis and follow-up of bladder cancer has
remained a challenge to the urologic community. Cystoscopy, commonly accepted as a gold …

Objectives Urine cell-free (UCF) DNA has recently been proposed as a potential marker for
early bladder cancer diagnosis. It is known that normal apoptotic cells produce highly …

Purpose To validate urinary markers for the early detection of bladder cancer (BC) in
chemical workers. Methods UroScreen was conducted as a validation study for tumor …

CONTEXT: Bladder cancer (BCa) is the fourth most common cancer in men. Survival from
the disease has not improved in the last 25 yr. Population-based screening theoretically …

Purpose To update current recommendations on prevention, screening, diagnosis, and
evaluation of bladder cancer (BC) based on a thorough assessment of the most recent …

Study Type–Diagnostic (non‐consecutive cohort without consistently applied reference
standard) Level of Evidence 3b What's known on the subject? and What does the study …

Objectives Up to 10% of Bladder Cancers may arise following occupational exposure to
carcinogens. We hypothesised that different cancer phenotypes reflected different patterns …